These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 19130618)

  • 1. Role of PET and combination PET/CT in the evaluation of patients with inflammatory bowel disease.
    Halpenny DF; Burke JP; Lawlor GO; O'Connell M
    Inflamm Bowel Dis; 2009 Jun; 15(6):951-8. PubMed ID: 19130618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive assessment of pediatric inflammatory bowel disease with ¹⁸F-fluorodeoxyglucose-positron emission tomography and computed tomography.
    Däbritz J; Jasper N; Loeffler M; Weckesser M; Foell D
    Eur J Gastroenterol Hepatol; 2011 Jan; 23(1):81-9. PubMed ID: 21042220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PET/CT imaging of inflammatory bowel disease.
    Perlman SB; Hall BS; Reichelderfer M
    Semin Nucl Med; 2013 Nov; 43(6):420-6. PubMed ID: 24094709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical utility of positron emission tomography/computed tomography in inflammatory bowel disease.
    Lapp RT; Spier BJ; Perlman SB; Jaskowiak CJ; Reichelderfer M
    Mol Imaging Biol; 2011 Jun; 13(3):573-576. PubMed ID: 20574849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
    Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDG-PET in inflammatory bowel disease.
    Spier BJ; Perlman SB; Reichelderfer M
    Q J Nucl Med Mol Imaging; 2009 Feb; 53(1):64-71. PubMed ID: 19182729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory bowel disease diagnosed with US, MR, scintigraphy, and CT: meta-analysis of prospective studies.
    Horsthuis K; Bipat S; Bennink RJ; Stoker J
    Radiology; 2008 Apr; 247(1):64-79. PubMed ID: 18372465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positron Emission Tomography/Magnetic Resonance Imaging for Local Tumor Staging in Patients With Primary Breast Cancer: A Comparison With Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging.
    Grueneisen J; Nagarajah J; Buchbender C; Hoffmann O; Schaarschmidt BM; Poeppel T; Forsting M; Quick HH; Umutlu L; Kinner S
    Invest Radiol; 2015 Aug; 50(8):505-13. PubMed ID: 26115367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Beware of PET-CT results in cases of cancer occurring in the setting of chronic inflammatory bowel disease].
    Bonaventure T; Goéré D; Boige V; Pocard M
    J Chir (Paris); 2009 Dec; 146(6):579-82. PubMed ID: 19906376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
    Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ¹⁸F-Fluorodeoxyglucose positron emission tomography/computed tomography finds answers in cancer patients with increasing tumor markers and negative or equivocal conventional imaging modalities.
    Salem SS; Shahin MA
    Nucl Med Commun; 2012 Mar; 33(3):313-21. PubMed ID: 22237387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET/CT in the evaluation of inflammatory bowel disease: studies in patients before and after treatment.
    Spier BJ; Perlman SB; Jaskowiak CJ; Reichelderfer M
    Mol Imaging Biol; 2010; 12(1):85-8. PubMed ID: 19430844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High diagnostic value of 18F-FDG-PET in pediatric patients with chronic inflammatory bowel disease.
    Löffler M; Weckesser M; Franzius C; Schober O; Zimmer KP
    Ann N Y Acad Sci; 2006 Aug; 1072():379-85. PubMed ID: 17057218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology.
    Jensen TK; Holt P; Gerke O; Riehmann M; Svolgaard B; Marcussen N; Bouchelouche K
    Scand J Urol Nephrol; 2011 Mar; 45(2):122-8. PubMed ID: 21231796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translational 18F-FDG PET/CT imaging to monitor lesion activity in intestinal inflammation.
    Bettenworth D; Reuter S; Hermann S; Weckesser M; Kerstiens L; Stratis A; Nowacki TM; Ross M; Lenze F; Edemir B; Maaser C; Pap T; Koschmieder S; Heidemann J; Schäfers M; Lügering A
    J Nucl Med; 2013 May; 54(5):748-55. PubMed ID: 23516311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of PET imaging in inflammatory bowel diseases: state-of-the-art review.
    Lovinfosse P; Hustinx R
    Q J Nucl Med Mol Imaging; 2022 Sep; 66(3):206-217. PubMed ID: 35708600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in diagnosis and management of pancreatic cancer; comparison with multidetector row computed tomography, magnetic resonance imaging and endoscopic ultrasonography.
    Ergul N; Gundogan C; Tozlu M; Toprak H; Kadıoglu H; Aydin M; Cermik TF
    Rev Esp Med Nucl Imagen Mol; 2014; 33(3):159-64. PubMed ID: 24140024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary peripheral T-cell lymphoma of the colon mimics inflammatory bowel disease: a potential pitfall with F-18 FDG PET/CT imaging.
    Ciarallo A; Makis W; Derbekyan V
    Clin Nucl Med; 2011 Jul; 36(7):e61-4. PubMed ID: 21637044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorodeoxyglucose positron emission tomography (FDG-PET) and PET/computed tomography imaging characteristics of thyroid lymphoma and their potential clinical utility.
    Basu S; Li G; Bural G; Alavi A
    Acta Radiol; 2009 Mar; 50(2):201-4. PubMed ID: 19089692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
    Metser U; Even-Sapir E
    Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.